乳腺癌预后指标的磁共振成像研究进展
Research Progress of Magnetic Resonance Imaging in Prognostic Indicators of Breast Cancer
DOI: 10.12677/ACM.2022.121037, PDF,   
作者: 陈 行, 印国兵：重庆医科大学附属第二医院乳甲外科，重庆
关键词: 乳腺癌；磁共振；预后指标；Breast Cancer； MRI； Prognostic Indicators
摘要: 乳腺癌是临床上最常见的恶性肿瘤，预后的好坏依赖于早期诊断，早期治疗。乳腺磁共振(Magnetic resonance imaging, MRI)因其灵敏度、分辨率高等优势在临床中广泛应用，尤其是动态增强磁共振(Dynamic contrast enhanced MRI, DCE-MRI)联合扩散加权成像(Diffusion-weighted imaging, DWI)更是提高了乳腺癌的早期诊断率，并以此为依据进行分期。乳腺癌的预后指标包括病理类型、分子分型、雌激素(estrogen receptor, ER)、孕激素受体(Progesterone receptor, PR)、人类表皮生长因子受体2 (Human epidermal growth factor receptor 2, Her2)、肿瘤增殖指数(Ki67)、淋巴结转移、有无脉管癌栓等。近年来，MRI成像特点与预后指标的相关性的研究成为了热点。本文就近年来该领域的研究所取得的进展进行综述。
Abstract: Breast cancer is the most common malignancy in clinical practice. Prognosis depends on early diagnosis and early treatment. Magnetic resonance imaging (MRI) is widely used in the clinic because of its high sensitivity and high resolution. In particular, Dynamic contrast enhanced MRI (DCE-MRI) combined with diffusion-weighted imaging (DWI) improves the early diagnosis rate of breast cancer. The prognostic indicators of breast cancer include pathological types, molecular typing, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (human epidermal growth factor receptor 2, Her2), tumor proliferation index (Ki67), lymph node metastasis, presence or absence of vascular tumor thrombus, etc. In recent years, the research on the correlation between MRI imaging characteristics and prognostic indicators has become a hot spot. This paper reviews the research progress in this field in recent years.
文章引用：陈行, 印国兵. 乳腺癌预后指标的磁共振成像研究进展[J]. 临床医学进展, 2022, 12(1): 246-251. https://doi.org/10.12677/ACM.2022.121037

参考文献

[1] DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., et al. (2014) Cancer Treatment and Survivorship Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 252-271. [Google Scholar] [CrossRef] [PubMed]
[2] Sutton, E.J., Dashevsky, B.Z., Oh, J.H., Veeraraghavan, H., Apte, A.P., Thakur, S.B., et al. (2016) Breast Cancer Molecular Subtype Classifier That Incorporates MRI Features. Journal of Magnetic Resonance Imaging: JMRI, 44, 122-129. [Google Scholar] [CrossRef] [PubMed]
[3] Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F.J., et al. (2010) Magnetic Resonance Imaging of the Breast: Recommendations from the EUSOMA Working Group. European Journal of Cancer (Oxford, England: 1990), 46, 1296-1316. [Google Scholar] [CrossRef] [PubMed]
[4] Goldhirsch, A., Wood, W.C., Coates, A.S., Gelber, R.D., Thürlimann, B. and Senn, H.J. (2011) Strategies for Subtypes—Dealing with the Diversity of Breast Cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 22, 1736-1747. [Google Scholar] [CrossRef] [PubMed]
[5] Howlader, N., Cronin, K.A., Kurian, A.W. and Andridge, R. (2018) Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, 27, 619-626. [Google Scholar] [CrossRef] 
[6] Allarakha, A., Gao, Y., Jiang, H. and Wang, P.J. (2019) Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers. Discovery Medicine, 27, 7-15.
[7] Kim, J.Y., Kim, S.H., Kim, Y.J., Kang, B.J., An, Y.Y., Lee, A.W., et al. (2015) Enhancement Parameters on Dynamic Contrast Enhanced Breast MRI: Do They Correlate with Prognostic Factors and Subtypes of Breast Cancers? Magnetic Resonance Imaging, 33, 72-80. [Google Scholar] [CrossRef] [PubMed]
[8] 孙琳琳, 张旭. 乳腺癌磁共振征象与生物学行为、分子分型的关系分析[J]. 生命科学仪器, 2020, 18(5): 35-40.
[9] Plaza, M.J., Handa, P. and Esserman, L.E. (2017) Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status. AJR American Journal of Roentgenology, 208, 910-915. [Google Scholar] [CrossRef] 
[10] Wu, M. and Ma, J. (2017) Association between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer. Academic Radiology, 24, 426-434. [Google Scholar] [CrossRef] [PubMed]
[11] Kawashima, H., Miyati, T., Ohno, N., Ohno, M., Inokuchi, M., Ikeda, H., et al. (2017) Differentiation between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Academic Radiology, 24, 1575-1581. [Google Scholar] [CrossRef] [PubMed]
[12] Martincich, L., Deantoni, V., Bertotto, I., Redana, S., Kubatzki, F., Sarotto, I., et al. (2012) Correlations between Diffusion-Weighted Imaging and Breast Cancer Biomarkers. European Radiology, 22, 1519-1528. [Google Scholar] [CrossRef] [PubMed]
[13] Yuan, C., Jin, F., Guo, X., Zhao, S., Li, W. and Guo, H. (2019) Correlation Analysis of Breast Cancer DWI Combined with DCE-MRI Imaging Features with Molecular Subtypes and Prognostic Factors. Journal of Medical Systems, 43, 83. [Google Scholar] [CrossRef] [PubMed]
[14] Jiang, S., Hong, Y.J., Zhang, F. and Li, Y.K. (2017) Computer-Aided Evaluation of the Correlation between MRI Morphology and Immunohistochemical Biomarkers or Molecular Subtypes in Breast Cancer. Scientific Reports, 7, Article No. 13818. [Google Scholar] [CrossRef] [PubMed]
[15] Kumar, P. and Aggarwal, R. (2016) An Overview of Triple-Negative Breast Cancer. Archives of Gynecology and Obstetrics, 293, 247-269. [Google Scholar] [CrossRef] [PubMed]
[16] Boisserie-Lacroix, M., Mac Grogan, G., Debled, M., Ferron, S., Asad-Syed, M., Brouste, V., et al. (2012) Radiological Features of Triple-Negative Breast Cancers (73 Cases). Diagnostic and Interventional Imaging, 93, 183-190. [Google Scholar] [CrossRef] [PubMed]
[17] Dogan, B.E. and Turnbull, L.W. (2012) Imaging of Triple-Negative Breast Cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 23, vi23-vi29. [Google Scholar] [CrossRef] [PubMed]
[18] Tian, L., Wang, L., Qin, Y. and Cai, J. (2020) Systematic Review and Meta-Analysis of the Malignant Ultrasound Features of Triple-Negative Breast Cancer. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine, 39, 2013-2025. [Google Scholar] [CrossRef] [PubMed]
[19] Uematsu, T. (2011) MR Imaging of Triple-Negative Breast Cancer. Breast Cancer (Tokyo, Japan), 18, 161-164. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, J.H., Agrawal, G., Feig, B., Baek, H.M., Carpenter, P.M., Mehta, R.S., et al. (2007) Triple-Negative Breast Cancer: MRI Features in 29 Patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 18, 2042-2043. [Google Scholar] [CrossRef] [PubMed]
[21] Sung, J.S., Jochelson, M.S., Brennan, S., Joo, S., Wen, Y.H., Moskowitz, C., et al. (2013) MR Imaging Features of Triple-Negative Breast Cancers. The Breast Journal, 19, 643-649. [Google Scholar] [CrossRef] [PubMed]
[22] Youk, J.H., Son, E.J., Chung, J., Kim, J.A. and Kim, E.K. (2012) Triple-Negative Invasive Breast Cancer on Dynamic Contrast-Enhanced and Diffusion-Weighted MR Imaging: Comparison with Other Breast Cancer Subtypes. European Radiology, 22, 1724-1734. [Google Scholar] [CrossRef] [PubMed]
[23] Moffa, G., Galati, F., Collalunga, E., Rizzo, V., Kripa, E., D’Amati, G., et al. (2020) Can MRI Biomarkers Predict Triple-Negative Breast Cancer? Diagnostics (Basel, Switzerland), 10, 1090. [Google Scholar] [CrossRef] [PubMed]
[24] Shang, L.T., Yang, J.F., Lu, J., Wang, T.T., Zhou, Y., Xing, X.B., et al. (2017) Correlations between Apparent Diffusion Coefficient in Diffusion? Weighted Magnetic Resonance Imaging and Molecular Subtypes of Invasive Breast Cancer Masses. Journal of Southern Medical University, 37, 1410-1414.
[25] Grimm, L.J., Zhang, J., Baker, J.A., Soo, M.S., Johnson, K.S. and Mazurowski, M.A. (2017) Relationships between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement Is Associated with Luminal B Subtype. The Breast Journal, 23, 579-582. [Google Scholar] [CrossRef] [PubMed]
[26] Michishita, S., Kim, S.J., Shimazu, K., Sota, Y., Naoi, Y., Maruyama, N., et al. (2015) Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy by Magnetic Resonance Imaging in Breast Cancer Patients. Breast (Edinburgh, Scotland), 24, 159-165. [Google Scholar] [CrossRef] [PubMed]
[27] Ha, R., Jin, B., Mango, V., Friedlander, L., Miloshev, V., Malak, S., et al. (2015) Breast Cancer Molecular Subtype as a Predictor of the Utility of Preoperative MRI. AJR American Journal of Roentgenology, 204, 1354-1360. [Google Scholar] [CrossRef] 
[28] Nielsen Moody, A., Bull, J., Culpan, A.M., Munyombwe, T., Sharma, N., Whitaker, M., et al. (2017) Preoperative Sentinel Lymph Node Identification, Biopsy and Localisation Using Contrast Enhanced Ultrasound (CEUS) in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. Clinical Radiology, 72, 959-971. [Google Scholar] [CrossRef] [PubMed]
[29] Carriero, A., Di Credico, A., Mansour, M. and Bonomo, L. (2002) Maximum Intensity Projection Analysis in Magnetic Resonance of the Breast. Journal of Experimental & Clinical Cancer Research: CR, 21, 77-81.
[30] Mori, N., Mugikura, S., Takasawa, C., Miyashita, M., Shimauchi, A., Ota, H., et al. (2016) Peritumoral Apparent Diffusion Coefficients for Prediction of Lymphovascular Invasion in Clinically Node-Negative Invasive Breast Cancer. European Radiology, 26, 331-339. [Google Scholar] [CrossRef] [PubMed]
[31] Cutuli, B., Velten, M. and Martin, C. (2001) Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases. Clinical Breast Cancer, 2, 59-65. [Google Scholar] [CrossRef] 
[32] Colpaert, C., Vermeulen, P., van Beest, P., Goovaerts, G., Weyler, J., Van Dam, P., et al. (2001) Intratumoral Hypoxia Resulting in the Presence of a Fibrotic Focus Is an Independent Predictor of Early Distant Relapse in Lymph Node-Negative Breast Cancer Patients. Histopathology, 39, 416-425. [Google Scholar] [CrossRef] [PubMed]
[33] Chang, Y.W., Kwon, K.H., Choi, D.L., Lee, D.W., Lee, M.H., Lee, H.K., et al. (2009) Magnetic Resonance Imaging of Breast Cancer and Correlation with Prognostic Factors. Acta Radiologica (Stockholm, Sweden: 1987), 50, 990-998. [Google Scholar] [CrossRef] [PubMed]
[34] Choi, E.J., Youk, J.H., Choi, H. and Song, J.S. (2020) Dynamic Contrast-Enhanced and Diffusion-Weighted MRI of Invasive Breast Cancer for the Prediction of Sentinel Lymph Node Status. Journal of Magnetic Resonance Imaging: JMRI, 51, 615-626. [Google Scholar] [CrossRef] [PubMed]
[35] 杨丽, 时高峰, 刘辉, 翟英敏, 周涛. 乳腺癌磁共振成像形态学特征与病理的相关性研究[J]. 临床荟萃, 2010, 25(19): 1680-1683.

为你推荐